MAPT and Cognitive impairment: In addition, the GSK3β-Tau signaling pathway was analyzed to explore the molecular mechanisms underlying RCN2-mediated synaptic regulation.<h4>Finding</h4>This study reveals that decreased expression of RCN2 in the hippocampus is associated with cognitive impairment.